Accutest CLEAR Benzodiazapine Drug Screen Dip & Read. *CLIA-Waived* 25 Tests/Ki

Basic Information

• Brand Name: Accutest CLEAR Benzodiazapine Drug Screen Dip & Read. *CLIA-Waived* 25 Tests/Ki
• Primary DI: 10763924323910
• Version / Model: DS323
• Company Name: JANT PHARMACAL CORPORATION
• Labeler DUNS: 797393659
• Distribution Status: In Commercial Distribution
• Device Count in Pkg: 25
• Record Status: Published
• Publish Date: 2016-09-20
• Public Version: 3
• Public Version Date: 2022-06-10
• Public Version Status: Update
• Public Device Record Key: f89257b8-3cbc-4a5a-9394-1d02ee4e6ab7

Device Description

Accutest CLEAR Benzodiazapine Drug Screen Dip & Read. *CLIA-Waived* 25 Tests/Kit

Device Characteristics

• Single Use: Yes
• Prescription Use (Rx): No
• Over the Counter (OTC): No
• Kit: Yes
• Combination Product: No
• HCT/P: No
• Contains NRL: No
• Not Made with NRL: No
• MRI Safety: Labeling does not contain MRI Safety Information
• Direct Marking Exempt: No
• PM Exempt: No
• Has Serial Number: No
• Has Lot/Batch Number: Yes
• Has Manufacturing Date: No
• Has Expiration Date: Yes
• Has Donation ID: No

Sterilization

• Is Sterile: No
• Sterilization Prior Use: No

Product Codes

Code	Name	Medical Specialty	Regulation #	Device Class
JXM	Enzyme Immunoassay, Benzodiazepine	Clinical Toxicology	862.3170	2

GMDN Terms

Code	Name	Definition	Implantable	Status
30518	Benzodiazepine group IVD, kit, rapid ICT, clinical	A collection of reagents and other associated materials intended to be used for the qualitative and/or (semi-)quantitative detection of benzodiazepine in a clinical specimen within a short period, relative to standard laboratory testing procedures, using an immunochromatographic test (ICT) method [lateral flow test]. This is a rapid test used in the laboratory or in point-of-care analyses. It is not intended to be used for self-testing.	No	Active

Identifiers

Type	ID	Issuing Agency	Package Type	Qty per Pkg	Pkg Status	Pkg Discontinue Date
Primary	10763924323910	GS1
Unit of Use	00763924323913	GS1